Digital Content 
NEWS #PharmaBuzz
17 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/17/2782524/0/en/Adlai-Nortye-Announces-Completion-of-Patient-Enrollment-in-Global-Phase-III-Clinical-Trial-of-Buparlisib-AN2025-in-Combination-with-Paclitaxel-for-the-Treatment-of-Recurrent-or-Met.html
15 Mar 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adlai-nortyes-buparlisib-an2025-set-to-become-a-potential-treatment-for-anti-pd-1-non-responding-tumor-in-hnscc-300813063.html
23 Aug 2018
// John Miller REUTERS
https://www.reuters.com/article/us-novartis-breast-cancer/novartis-trial-win-lifts-profile-of-new-breast-cancer-drug-idUSKCN1L80PM
23 Aug 2018
// John Carroll ENDPTS
https://endpts.com/novartis-just-boasted-of-a-big-phiii-pi3k-success-but-heres-why-we-should-hold-our-applause-for-now/
23 Aug 2018
// Piotr Wnuk PHARMAPHORUM
https://pharmaphorum.com/news/novartis-success-breast-cancer-inhibitor/
30 Jul 2018
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adlai-nortye-announces-the-publication-of-the-biomarker-analysis-from-beril-1-the-buparlisib-study-in-hnscc-895401608.html
LOOKING FOR A SUPPLIER?
Share